Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lung and the Predictive Value of miR-375. The LANCE Trial, a Pilot Study
How to cite: Evangelou, G.; Trontzas, I. P.; Gkiozos, I.; Vamvakaris, I.; Grammoustianou, M.; Paraskeva, C.; Gomatou, G.; Tsamis, I.; Vathiotis, I. A.; Anagnostakis, M.; Koliaraki, V.; Syrigos, K. Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lung and the Predictive Value of miR-375. The LANCE Trial, a Pilot Study. Preprints 2024, 2024030593. https://doi.org/10.20944/preprints202403.0593.v1 Evangelou, G.; Trontzas, I. P.; Gkiozos, I.; Vamvakaris, I.; Grammoustianou, M.; Paraskeva, C.; Gomatou, G.; Tsamis, I.; Vathiotis, I. A.; Anagnostakis, M.; Koliaraki, V.; Syrigos, K. Effectiveness of Atezolizumab in Metastatic Large Cell Neuroendocrine Carcinoma of the Lung and the Predictive Value of miR-375. The LANCE Trial, a Pilot Study. Preprints 2024, 2024030593. https://doi.org/10.20944/preprints202403.0593.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)